These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2065696)

  • 1. The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes.
    Ferner RE; Antsiferov ML; Kelman AW; Alberti KG; Rawlins MD
    Eur J Clin Pharmacol; 1991; 40(2):163-8. PubMed ID: 2065696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glucose response after intravenous injection of tolbutamide in insulin-treated type I and type II diabetic patients.
    Mokuda O; Murakami I; Ikeda T; Tominaga M; Mashiba H
    Exp Clin Endocrinol; 1988 Aug; 91(3):265-70. PubMed ID: 3075183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of interaction between fluvastatin and oral hypoglycemic agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus.
    Appel S; Rüfenacht T; Kalafsky G; Tetzloff W; Kallay Z; Hitzenberger G; Kutz K
    Am J Cardiol; 1995 Jul; 76(2):29A-32A. PubMed ID: 7604792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a very low dose of tolbutamide combined with an alpha-glucosidase inhibitor in non-insulin-dependent diabetes mellitus.
    Okada S; Ishii K; Hamada H; Tanokuchi S; Ichiki K; Ota Z
    J Int Med Res; 1996; 24(5):433-7. PubMed ID: 8895047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination treatment with insulin and sulfonylurea. Results of a 5-year study].
    Holländer E
    Z Gesamte Inn Med; 1989 May; 44(9):261-4. PubMed ID: 2662659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
    Giugliano D; Ceriello A; Saccomanno F; Quatraro A; Paolisso G; D'Onofrio F
    J Clin Endocrinol Metab; 1985 Jul; 61(1):160-6. PubMed ID: 3923028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antidiabetics on post-exercise alaninemia in patients with non-insulin-dependent diabetes mellitus (type 2)].
    Czyzyk A; Lao B; Orłowska K; Szczepanik Z; Bartosiewicz W
    Pol Arch Med Wewn; 1989 Apr; 81(4):193-206. PubMed ID: 2516627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets.
    Ishiyama N; Ravier MA; Henquin JC
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E540-9. PubMed ID: 16249257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
    Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective acute insulin secretion in diabetics. Differences between normal weight and obese subjects.
    Vague P; Ramahandridona G; Vialettes B; Raymond JP; Vague J
    Diabete Metab; 1978 Dec; 4(4):261-5. PubMed ID: 729892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of plasma insulin to small doses of tolbutamide in obesity and acromegaly.
    Pelkonen R; Taskinen MR; Nikkilä EA
    Int J Obes; 1977; 1(4):315-24. PubMed ID: 617112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
    Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
    Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
    Ganda OP; Kahn CB; Soeldner JS; Gleason RE
    Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic blockade with pirenzepine induces dose-related reduction in glucose and insulin responses to a mixed meal in normal subjects and non-insulin dependent diabetics.
    Bevan JS; Ara J; Page MD; Scanlon MF; Peters JR
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):85-91. PubMed ID: 1889143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
    Heine P; Kewitz H; Schnapperelle U
    Eur J Clin Pharmacol; 1974 Aug; 7(5):321-30. PubMed ID: 4213593
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence that insulin can directly inhibit hepatic glucose production.
    Maheux P; Chen YD; Polonsky KS; Reaven GM
    Diabetologia; 1997 Nov; 40(11):1300-6. PubMed ID: 9389422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.